, Dynamics of the immunological synapse: finding, establishing and solidifying a connection, Current Opinion in Immunology, vol.14, issue.1, pp.66-74, 2002.
DOI : 10.1016/S0952-7915(01)00299-0
, Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule, Clin. Immunol, vol.119, pp.38-50, 2006.
, In vitro anti-tumoral mechanisms of baculovirus-expressed recombinant anti-CD4 antibody 13B8.2 on T cell lymphomas, J. Immunother, pp.30-190, 2007.
, Recombinant anti-CD4 antibody 13B8.2 blocks membrane-proximal events by excluding the Zap70 molecule and downstream targets SLP-76, PLC gamma 1, and Vav-1 from the CD4- segregated Brij 98 detergent-resistant raft domains, J. Immunol, pp.179-409, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00170828
, The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts, Immunol. Lett, vol.133, pp.62-69, 2010.
, CD3+ WT31-peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the alpha/beta heterodimer, Eur. J. Immunol, pp.17-1065, 1987.
, Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NFkappaB activation, FEBS Lett, pp.496-121, 2001.
, CARMA1 is a critical lipid raft???associated regulator of TCR-induced NF-??B activation, Nature Immunology, vol.3, issue.9, pp.836-843, 2002.
DOI : 10.1038/ni830
, The MAGUK family protein CARD11 is essential for lymphocyte activation, Immunity, vol.18, pp.763-775, 2003.
, Littman Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation, Curr. Biol, pp.13-1252, 2003.
, MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation, J Biol Chem, pp.279-15870, 2004.
, Determining the Destiny of NF-?? B after TCR Ligation: It's CARMA1, Molecular Interventions, vol.2, issue.6, pp.356-360, 2002.
DOI : 10.1124/mi.2.6.356
, A requirement for CARMA1 in TCR-induced NF-kappa B activation, Nat. Immunol, vol.3, pp.830-835, 2002.
, The chimeric mousehuman anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation, Hum. Antibodies, vol.10, pp.67-76, 2001.
, A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by, pp.216-228, 2005.
, A guided tour into subcellular colocalization analysis in light microscopy, Journal of Microscopy, vol.56, issue.3, pp.213-232, 2006.
DOI : 10.1016/S0014-5793(03)00521-0
URL : https://hal.archives-ouvertes.fr/hal-00132481
, Phosphorylation of CARMA1 plays a critical role in T Cell receptormediated NF-kappaB activation, Immunity, vol.23, pp.575-585, 2005.
, Phosphorylation of the CARMA1 linker controls NF-kappaB activation, Immunity, pp.23-561, 2005.
, Serine 649 Phosphorylation within the Protein Kinase C-Regulated Domain Down-Regulates CARMA1 Activity in Lymphocytes, J. Immunol, vol.183, pp.7362-7370, 2009.
, Ceramide inhibits IL-2 production by preventing protein kinase C-dependent NF-kappaB activation: possible role in protein kinase Ctheta regulation, J. Immunol, pp.173-3193, 2004.
, High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays, Leukemia, pp.22-1891, 2008.
, Antiapoptotic Function of Apoptosis Inhibitor 2-MALT1 Fusion Protein Involved in t(11;18)(q21;q21) Mucosa-Associated Lymphoid Tissue Lymphoma, Cancer Research, vol.64, issue.10, pp.3452-3457, 2004.
DOI : 10.1158/0008-5472.CAN-03-3677
, MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells, Blood, pp.105-2891, 2005.
, Bcl10 can promote survival of antigen-stimulated B lymphocytes, Blood, vol.106, issue.6, pp.2105-2112, 2005.
DOI : 10.1182/blood-2004-04-1248
, Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma, Blood, vol.107, issue.11, pp.4500-4507, 2006.
DOI : 10.1182/blood-2005-09-3801
, CARMA1 Is Critical for the Development of Allergic Airway Inflammation in a Murine Model of Asthma, The Journal of Immunology, vol.176, issue.12, pp.7272-7277, 2006.
DOI : 10.4049/jimmunol.176.12.7272
, 18)(q21;q21) is the most common translocation in MALT lymphomas, Annals of Oncology, vol.8, issue.10, pp.979-985, 1997.
DOI : 10.1023/A:1008202303666
, The role of the NF??B signalling pathway in cancer, Clinical and Translational Oncology, vol.25, issue.3, pp.143-147, 2008.
DOI : 10.1007/s12094-008-0171-3
, Proteasome inhibitor bortezomib for the treatment of multiple myeloma, Leukemia, vol.106, issue.8, pp.1341-1352, 2006.
DOI : 10.1038/sj.leu.2404278
, Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma, J. Clin. Oncol, pp.25-4293, 2007.
, Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma, Ann. Oncol, vol.19, pp.2079-2083, 2008.
, Antisense inhibition of the p65 subunit of NFkappa B blocks tumorigenicity and causes tumor regression, Proc. Natl. Acad. Sci
, Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling, Curr. Opin. Mol. Ther, vol.12, pp.147-157, 2010.
, NFkappaB decoy oligonucleotides, Curr. Opin. Mol. Ther, vol.12, pp.203-213, 2010.
, BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice, J. Biol. Chem, pp.278-1450, 2003.
, Novel IKK inhibitors: beta-carbolines